CFO
James Budge is a seasoned financial executive serving as the Chief Financial Officer (CFO) of Hinge Health, Inc. (HNGE) since March 2023.[[1]](https://www.hingehealth.com/resources/press-releases/james-budge-chief-financial-officer/)[[2]](https://www.clay.com/dossier/hinge-health-cfo)[[5]](https://ir.hingehealth.com/governance/executive-management/default.aspx) With over 25 years of experience, he has held CFO roles at high-growth technology companies including Automation Anywhere (2021-2023), Pluralsight (2017-2021), Anaplan (2016-2017), Genesys (2012-2016), TiVo Corporation (2005-2012), Trados (2004-2005), and others, where he raised billions in capital, took companies public, and oversaw dozens of acquisitions.[[1]](https://www.hingehealth.com/resources/press-releases/james-budge-chief-financial-officer/)[[2]](https://www.clay.com/dossier/hinge-health-cfo)[[3]](https://theorg.com/org/hinge-health/org-chart/james-budge) Budge earned a Bachelor’s degree in Accounting from Brigham Young University and currently serves as a board member at Shadowbox, Inc.[[1]](https://www.hingehealth.com/resources/press-releases/james-budge-chief-financial-officer/)[[2]](https://www.clay.com/dossier/hinge-health-cfo)[[3]](https://theorg.com/org/hinge-health/org-chart/james-budge)
In his role at Hinge Health, a leading digital clinic for musculoskeletal health, Budge drives financial strategy and sustainable growth amid the company's expansion, including recent enterprise milestones and acquisitions.[[1]](https://www.hingehealth.com/resources/press-releases/james-budge-chief-financial-officer/)[[5]](https://ir.hingehealth.com/governance/executive-management/default.aspx) On December 22, 2025, he sold 10,491 shares of HNGE Class A Common Stock for approximately $507,836 under a Rule 10b5-1 plan, retaining 441,174 shares.[[4]](https://www.investing.com/news/insider-trading-news/hinge-health-cfo-budge-sells-507836-in-stock-93CH-4421835)
View full insider profile →
Discussion